Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.0K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.2K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary function estimation using smartphone audio and deep learning.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2025
Same author

The MUSIC trial: harmonising our understanding of inhaled corticosteroids and the COPD airway microbiome.

The European respiratory journal·2025
Same author

Evaluation of the accuracy of ChatGPT in answering asthma-related questions.

Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia·2025
Same author

Transcriptomic profiling of the airway epithelium in COPD links airway eosinophilia to type 2 inflammation and corticosteroid response.

The European respiratory journal·2025
Same author

Exploring Inflammatory Asthma Phenotypes: Proteomic Signatures in Serum and Induced Sputum.

International journal of molecular sciences·2024
Same author

Characterization of the Lower Airways and Oral Microbiota in Healthy Young Persons in the Community.

Biomedicines·2023

Related Experiment Video

Updated: Jan 7, 2026

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.5K

Asthma-Associated COPD Etiotype: Clinical Features and Inflammatory Patterns in Biological Samples.

Camyla Fernandez de Farias1, José Baddini-Martinez1, Ana Luisa Godoy Fernandes1

  • 1Division of Respiratory Medicine, Department of Medicine, Universidade Federal de São Paulo, São Paulo 04024-002, Brazil.

Journal of Personalized Medicine
|December 24, 2025
PubMed
Summary

Over 40% of non-smoking asthmatics develop chronic obstructive pulmonary disease with obstruction in the airway (COPD-A). Elevated sputum IL-8 levels may indicate this COPD-A phenotype in asthma patients.

Keywords:
asthmachronic obstructiveinterleukin-8nasal lavagepulmonary diseasesputum

More Related Videos

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

23.2K

Related Experiment Videos

Last Updated: Jan 7, 2026

Methodology for Sputum Induction and Laboratory Processing
13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.5K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K
A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
09:58

A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice

Published on: April 13, 2010

23.2K

Area of Science:

  • Pulmonology
  • Respiratory Medicine
  • Immunology

Background:

  • Asthma is recognized as a potential cause of chronic obstructive pulmonary disease (COPD), termed the COPD-A etiotype.
  • The clinical and inflammatory features of the COPD-A phenotype are not well understood.
  • This study investigates COPD-A in non-smoking asthmatics.

Purpose of the Study:

  • To characterize the clinical traits of stable asthmatics with persistent airflow limitation indicative of COPD-A.
  • To analyze cytokine profiles in asthmatic patients with and without COPD-A.
  • To identify potential biomarkers for the COPD-A phenotype.

Main Methods:

  • A cross-sectional study of 94 stable asthmatics without significant smoking or environmental exposures.
  • COPD-A was defined by post-bronchodilator FEV1/FVC ratio < 0.70.
  • Assessed asthma control, quality of life, lung function, and quantified cytokines (IL-5, IL-8, IL-13, IL-17A, IL-17F, IL-25, IL-33, TNF) in nasal lavage, sputum, and blood.

Main Results:

  • 44.7% of participants met COPD-A criteria.
  • COPD-A patients were older, had longer disease duration, lower FEV1, and poorer asthma control compared to non-COPD-A.
  • Elevated IL-8 levels in induced sputum were significantly higher in the COPD-A group and independently predicted COPD-A.

Conclusions:

  • Persistent airflow limitation consistent with COPD-A is prevalent in over 40% of non-smoking asthmatics.
  • Elevated sputum IL-8 concentrations may serve as a potential biomarker for identifying the COPD-A etiotype.
  • Further research is warranted to elucidate the mechanisms and clinical implications of COPD-A.